Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ)

Clinical trial NCT05422053 · COMPLETED

Trial details

NCT number: NCT05422053
Sponsor: Tandem Diabetes Care, Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Type 1 Diabetes

Start date: 2022-06-29
Primary completion: 2023-01-06
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.